News

The company will use Mobile Intelligence for its primary care, specialty, key account management and over-the-counter commercial teams. Mobile Intelligence features an intuitive Graphic User Interface (GUI) for

The DSIMS software is a repository, unified data model, viewer and analytical tool behind the FDA’s Nonclinical Information Management Solution (NIMS). FDA reviewers will use NIMS to view,

INyDIA will provide My5-FU test kits to laboratories, enabling oncologists to individualize 5-FU dosing to optimize therapeutic efficacy and reduce toxicity for their patients. My5-FU measures levels of

The collaboration will investigate and evaluate the implementation of a pharmacogenetic program in a community pharmacy. The study involves a protocol jointly developed by Kerr Drug and UNC

HQK-1001 is an orally administered Short Chain Fatty Acid Derivative (SCFAD), and has been evaluated in a number of clinical trials in sickle cell disease and beta thalassemia.

The Mevopur colorants block UV, thereby helping to protect UV sensitive pharmaceutical products. The pre-evaluated Mevopur colourants help reduce customers’ development times and costs, and minimize risk of

The study will evaluate the oral bioavailability of RX-3117 in humans. The company will continue the enrollment through the first half of 2012 and expects to release the

As per the agreement, the use of pSivida’s technology as a delivery system for a treatment for dry age related macular degeneration (Dry AMD) will be evaluated. pSivida

MN-166 is used for certain neurological conditions, including progressive forms of multiple sclerosis, neuropathic pain, and drug addiction. The patent once received is expected to expire by the